+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Immunotherapy"

From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
Cancer & Antibody Conjugates Patent Landscape Analysis 2025 - Product Thumbnail Image

Cancer & Antibody Conjugates Patent Landscape Analysis 2025

  • Report
  • December 2025
  • 100 Pages +
  • Global
Biological Therapies for Cancer: Technologies and Global Markets - Product Thumbnail Image

Biological Therapies for Cancer: Technologies and Global Markets

  • Report
  • November 2025
  • 139 Pages
  • Global
From
Neoantigen Targeted Therapy Market in United States - Product Thumbnail Image

Neoantigen Targeted Therapy Market in United States

  • Report
  • December 2025
  • 150 Pages
  • United States
From
Loading Indicator

Cancer Immunotherapy is a type of Immune Disorders Drugs that uses the body's own immune system to fight cancer. It works by stimulating the body's natural defense system to recognize and attack cancer cells. This type of therapy is used to treat a variety of cancers, including melanoma, lymphoma, and leukemia. It can also be used to treat other types of cancer, such as breast, lung, and colorectal cancer. Cancer Immunotherapy is a rapidly growing field, with many new treatments being developed. It is an important part of the overall cancer treatment landscape, as it can provide a more targeted approach to treating cancer. It can also be used in combination with other treatments, such as chemotherapy and radiation therapy, to improve outcomes. Some of the companies in the Cancer Immunotherapy market include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Roche. These companies are developing a range of treatments, including monoclonal antibodies, vaccines, and cell-based therapies. Show Less Read more